\r\n\t \r","showSummary":null,"url":"/otc/ada-now-recommends-diabetics-perform-light-activity-every-0-minutes","date":"2016-10-26T00:00:00","author":{"email":null,"uname":"Anonymous","firstName":null,"lastName":null,"bio":null,"title":null,"picture":null,"phone":null,"contactForm":null},"digitalEdition":null,"sponsored":false,"taggedPro":null,"teaserImage":{"id":59437,"url":"https://assets1.drugstorenews.com/styles/secondary_articles_short/s3/teaser_image_386723.jpg?itok=9Daadldx","width":767,"height":575,"alt":null},"topics":[{"name":"News","url":"/news"},{"name":"PHARMACY","url":"/pharmacy"},{"name":"HEALTH","url":"/health"},{"name":"Retail Clinics","url":"/retail-clinics"},{"name":"Diabetes","url":"/diabetes"}],"attachedFiles":[]},{"title":"Dr. Reddy’s inks strategic deal for 8 injectables with Gland Pharma","id":26751,"bundle":"article","summary":"
\r\n\tHYDERABAD, INDIA and PRINCETON, N.J. — Dr. Reddy’s Laboratories and Gland Pharma have announced a strategic collaboration to market and distribute eight injectable generics.
\r\n
\r\n\t
\r\n
\r\n\tThe portfolio includes hospital- and clinic-administered products for which abbreviated new drug applications (ANDAs) have been filed, and some whose ANDAs will be filed imminently, the companies said. The combined U.S. sales of the drugs for 12 months ending August 2016 were about $1 billion, according to IMS Health moving annual total data.
\r","showSummary":null,"url":"/pharmacy/dr-reddys-inks-strategic-deal-injectables-gland-pharma","date":"2016-10-26T00:00:00","author":{"email":null,"uname":"Anonymous","firstName":null,"lastName":null,"bio":null,"title":null,"picture":null,"phone":null,"contactForm":null},"digitalEdition":null,"sponsored":false,"taggedPro":null,"teaserImage":{"id":59447,"url":"https://assets1.drugstorenews.com/styles/secondary_articles_short/s3/teaser_image_386734.jpg?itok=SSH1Wi8p","width":767,"height":575,"alt":null},"topics":[{"name":"News","url":"/news"},{"name":"PHARMACY","url":"/pharmacy"},{"name":"Generics","url":"/generics"},{"name":"Retail Clinics","url":"/retail-clinics"}],"attachedFiles":[]},{"title":"Kaléo’s Auvi-Q auto-injector to return to U.S. in 2017","id":26752,"bundle":"article","summary":"
\r\n\tRICHMOND, Va. — Kaléo announced Wednesday that it will be reintroducing its Auvi-Q (epinephrine injection) auto-injector in the United States during the first half of 2017. This would bring another option to the epinephrine auto-injector space at a time when access and affordability in the space have seen focus from patients and legislators.
\r\n
\r\n\t
\r\n
\r","showSummary":null,"url":"/pharmacy/kalos-auvi-q-auto-injector-return-us-01","date":"2016-10-26T00:00:00","author":{"email":null,"uname":"Anonymous","firstName":null,"lastName":null,"bio":null,"title":null,"picture":null,"phone":null,"contactForm":null},"digitalEdition":null,"sponsored":false,"taggedPro":null,"teaserImage":{"id":59446,"url":"https://assets1.drugstorenews.com/styles/secondary_articles_short/s3/teaser_image_386733.jpg?itok=TmZb6Eiv","width":767,"height":575,"alt":null},"topics":[{"name":"News","url":"/news"},{"name":"PHARMACY","url":"/pharmacy"},{"name":"Branded","url":"/branded"},{"name":"Retail Clinics","url":"/retail-clinics"}],"attachedFiles":[]},{"title":"CDC makes available $70 million in supplemental Zika virus funding","id":26789,"bundle":"article","summary":"
ATLANTA - The Centers for Disease Control and Prevention on Friday announced the availability of about $70 million in supplemental funding to states, cities and territories to support continued efforts to protect Americans from Zika virus. \r\n\t \r","showSummary":null,"url":"/otc/cdc-makes-available-0-million-supplemental-zika-virus-funding","date":"2016-10-24T00:00:00","author":{"email":null,"uname":"Anonymous","firstName":null,"lastName":null,"bio":null,"title":null,"picture":null,"phone":null,"contactForm":null},"digitalEdition":null,"sponsored":false,"taggedPro":null,"teaserImage":{"id":59410,"url":"https://assets1.drugstorenews.com/styles/secondary_articles_short/s3/teaser_image_386694.jpg?itok=YfJa9W_G","width":767,"height":575,"alt":null},"topics":[{"name":"News","url":"/news"},{"name":"PHARMACY","url":"/pharmacy"},{"name":"HEALTH","url":"/health"},{"name":"Retail Clinics","url":"/retail-clinics"},{"name":"Regulatory and Washington","url":"/regulatory-and-washington"}],"attachedFiles":[]},{"title":"Hisamitsu launches Salonpas gel patch","id":26894,"bundle":"article","summary":"
\r\n\tFLORHAM PARK, N.J. — Hisamitsu America has launched the new Salonpas Lidocaine 4% Pain Relieving Gel-Patch, the company announced Monday. The patch includes the maximum strength lidocaine available without a prescription and uses a proprietary hydro-gel technology to soothe aggravated nerves, the company said.
\r\n\tNEW YORK — Napo Pharmaceuticals on Thursday announced the launch of its Mytesi (crofelemer), approved by the Food and Drug Administration as a treatment for non-infectious diarrhea in patients with HIV/AIDS on retroviral therapy. The active ingredient is a plant-based drug extracted from the red bark sap of a tree in the Amazon, for which Napo has set up a sustainable harvesting program.
\r\n\tSILVER SPRING, Md. — The Food and Drug Administration has approved Protein Sciences’s Flublok Quadrivalent flu vaccine, the company announced Wednesday. The vaccine protects against four strains of influenza, three of which are found in trivalent Flublok alongside a fourth strain.
\r\n
\r\n\t
\r\n
\r","showSummary":null,"url":"/pharmacy/fda-approves-flublok-quadrivalent-flu-vaccine","date":"2016-10-12T00:00:00","author":{"email":null,"uname":"Anonymous","firstName":null,"lastName":null,"bio":null,"title":null,"picture":null,"phone":null,"contactForm":null},"digitalEdition":null,"sponsored":false,"taggedPro":null,"teaserImage":{"id":59261,"url":"https://assets1.drugstorenews.com/styles/secondary_articles_short/s3/teaser_image_386520.jpg?itok=LSme0gi1","width":767,"height":575,"alt":null},"topics":[{"name":"News","url":"/news"},{"name":"PHARMACY","url":"/pharmacy"},{"name":"Branded","url":"/branded"},{"name":"Retail Clinics","url":"/retail-clinics"}],"attachedFiles":[]},{"title":"Merck signs value-based contract with Aetna for Januvia, Janumet","id":26935,"bundle":"article","summary":"
\r\n\tHARTFORD, Conn. — Merck and Aetna have entered into a value-based agreement for Merck’s Type diabetes medications Januvia (sitagliptin) and Janumet (sitagliptin plus metformin. The contract will see Merck’s rebates for the drugs based partly on their ability to help Aetna’s commercial members with Type 2 diabetes achieve or maintain treatment goals.
\r\n
\r\n\t
\r\n
\r","showSummary":null,"url":"/pharmacy/merck-signs-value-based-contract-aetna-januvia-janumet","date":"2016-10-12T00:00:00","author":{"email":null,"uname":"Anonymous","firstName":null,"lastName":null,"bio":null,"title":null,"picture":null,"phone":null,"contactForm":null},"digitalEdition":null,"sponsored":false,"taggedPro":null,"teaserImage":{"id":59265,"url":"https://assets1.drugstorenews.com/styles/secondary_articles_short/s3/teaser_image_386524.jpg?itok=rpKqQtzh","width":767,"height":575,"alt":null},"topics":[{"name":"News","url":"/news"},{"name":"PHARMACY","url":"/pharmacy"},{"name":"Branded","url":"/branded"},{"name":"Retail Clinics","url":"/retail-clinics"}],"attachedFiles":[]},{"title":"Safeway to open weight loss clinics in 5 Bay Area stores","id":26990,"bundle":"article","summary":"
\r\n\tSAN FRANCISCO — Weight loss clinics will soon be coming to several Bay Area Safeway stores. Safeway, alongside Costa Mesa, Calif.-based weight loss clinic chain Lean for Life By Lindora Clinic, announced Friday that Lean for Life by Lindora Clinics will be opening on Oct. 10 at five Safeway stores in Danville, Dublin, Livermore, Menlo Park and San Jose.
LAS VEGAS — In a move aimed at addressing the two challenges of discovering new options for treatment and improving chronic disease management, Teva and IBM on Wednesday announced an expansion of their e-health alliance, with both projects running on the IBM Watson Health Cloud.
ALEXANDRIA, Va. - The American Diabetes Association on Tuesday released updated, comprehensive guidelines for regular, structured physical exercise for everyone with diabetes and recommends less overall sedentary time every day.
HYDERABAD, INDIA and PRINCETON, N.J. — Dr. Reddy’s Laboratories and Gland Pharma have announced a strategic collaboration to market and distribute eight injectable generics.
The portfolio includes hospital- and clinic-administered products for which abbreviated new drug applications (ANDAs) have been filed, and some whose ANDAs will be filed imminently, the companies said. The combined U.S. sales of the drugs for 12 months ending August 2016 were about $1 billion, according to IMS Health moving annual total data.
RICHMOND, Va. — Kaléo announced Wednesday that it will be reintroducing its Auvi-Q (epinephrine injection) auto-injector in the United States during the first half of 2017. This would bring another option to the epinephrine auto-injector space at a time when access and affordability in the space have seen focus from patients and legislators.
ATLANTA - The Centers for Disease Control and Prevention on Friday announced the availability of about $70 million in supplemental funding to states, cities and territories to support continued efforts to protect Americans from Zika virus.
FLORHAM PARK, N.J. — Hisamitsu America has launched the new Salonpas Lidocaine 4% Pain Relieving Gel-Patch, the company announced Monday. The patch includes the maximum strength lidocaine available without a prescription and uses a proprietary hydro-gel technology to soothe aggravated nerves, the company said.
NEW YORK — Napo Pharmaceuticals on Thursday announced the launch of its Mytesi (crofelemer), approved by the Food and Drug Administration as a treatment for non-infectious diarrhea in patients with HIV/AIDS on retroviral therapy. The active ingredient is a plant-based drug extracted from the red bark sap of a tree in the Amazon, for which Napo has set up a sustainable harvesting program.
SILVER SPRING, Md. — The Food and Drug Administration has approved Protein Sciences’s Flublok Quadrivalent flu vaccine, the company announced Wednesday. The vaccine protects against four strains of influenza, three of which are found in trivalent Flublok alongside a fourth strain.
HARTFORD, Conn. — Merck and Aetna have entered into a value-based agreement for Merck’s Type diabetes medications Januvia (sitagliptin) and Janumet (sitagliptin plus metformin. The contract will see Merck’s rebates for the drugs based partly on their ability to help Aetna’s commercial members with Type 2 diabetes achieve or maintain treatment goals.
SAN FRANCISCO — Weight loss clinics will soon be coming to several Bay Area Safeway stores. Safeway, alongside Costa Mesa, Calif.-based weight loss clinic chain Lean for Life By Lindora Clinic, announced Friday that Lean for Life by Lindora Clinics will be opening on Oct. 10 at five Safeway stores in Danville, Dublin, Livermore, Menlo Park and San Jose.